A Study of YL201 in Patients With Advanced Solid Tumors

Clinical trial NCT05434234 · RECRUITING

Trial details

NCT number: NCT05434234
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2022-05-25
Primary completion: 2027-04-06
Enrollment: 312

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.